Nundina › Kalender entdecken › FDA-Zulassungen neuer Arzneimittel-Kalender › FDA approves Lamlique (lamotrigine hemifumarate)FDA approves Lamlique (lamotrigine hemifumarate)25. September 2026The FDA approved Lamlique (lamotrigine hemifumarate), a drug from Azurity. Form: Suspension, Oral. Application NDA221109.FDA-Zulassungen neuer Arzneimittel-KalenderMehr aus diesem Kalender